Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alex Friedlaender

Showing results (21-30 of 106) with videos related to

Pageof 11
Sort By:
ESMO Open|November 5, 2020
Gender-specific aspects of epidemiology, molecular genetics and outcome: lung cancerNuria Mederos, Alex Friedlaender, Solange Peters, et al.
Cancer Genomics & Proteomics|August 30, 2020
Influence of Concurrent Mutations on Overall Survival in EGFR-mutated Non-small Cell Lung CancerMathieu Chevallier, Petros Tsantoulis, Alfredo Addeo, et al.
Cancer Genomics & Proteomics|October 30, 2019
The Activity of Immune Checkpoint Inhibition in KRAS Mutated Non-small Cell Lung Cancer: A Single Centre ExperienceJavier Torralvo, Alex Friedlaender, Verane Achard, et al.
Immunotherapy|March 12, 2024
Metastatic gastric cancer: synergizing and sequencing targeted therapy with first-line immunotherapyGina Colarusso, Hiba Mechahougui, Thibaud Koessler, et al.
Current Treatment Options in Oncology|September 5, 2019
Diagnosis and Treatment of ALK Aberrations in Metastatic NSCLCAlex Friedlaender, Giuseppe Banna, Sandip Patel, et al.
Cancer Journal (Sudbury, Mass.)|November 16, 2022
Antibody Drug Conjugates in Lung CancerGeoffrey Merle, Alex Friedlaender, Aakash Desai, et al.
Exploration of Targeted Anti-Tumor Therapy|March 11, 2024
Management of stage III non-small-cell lung cancer: rays of hopeFloryane Kim, Maxime Borgeaud, Alfredo Addeo, et al.
Clinical Medicine Insights. Oncology|July 26, 2023
Pleural Mesothelioma in the Era of ImmunotherapyMathieu Chevallier, Floryane Kim, Alex Friedlaender, et al.
Revue Medicale Suisse|June 22, 2017
[Supportive care in oncology: a real change for patients?]Alex Friedlaender, Samuel Blaser, Christophe Luthy, et al.
Case Reports in Oncology|March 29, 2021
Vertebral Metastasis Treated by Vertebroplasty, a Cause of Respiratory Failure: Case Report and Literature ReviewMathieu Chevallier, Chloé Chevallier-Lugon, Alex Friedlaender, et al.
Pageof 11

Showing results (21-30 of 106) with videos related to

Sort By:
Pageof 11
ESMO Open|November 5, 2020
Gender-specific aspects of epidemiology, molecular genetics and outcome: lung cancerNuria Mederos, Alex Friedlaender, Solange Peters, et al.
Cancer Genomics & Proteomics|August 30, 2020
Influence of Concurrent Mutations on Overall Survival in EGFR-mutated Non-small Cell Lung CancerMathieu Chevallier, Petros Tsantoulis, Alfredo Addeo, et al.
Cancer Genomics & Proteomics|October 30, 2019
The Activity of Immune Checkpoint Inhibition in KRAS Mutated Non-small Cell Lung Cancer: A Single Centre ExperienceJavier Torralvo, Alex Friedlaender, Verane Achard, et al.
Immunotherapy|March 12, 2024
Metastatic gastric cancer: synergizing and sequencing targeted therapy with first-line immunotherapyGina Colarusso, Hiba Mechahougui, Thibaud Koessler, et al.
Current Treatment Options in Oncology|September 5, 2019
Diagnosis and Treatment of ALK Aberrations in Metastatic NSCLCAlex Friedlaender, Giuseppe Banna, Sandip Patel, et al.
Cancer Journal (Sudbury, Mass.)|November 16, 2022
Antibody Drug Conjugates in Lung CancerGeoffrey Merle, Alex Friedlaender, Aakash Desai, et al.
Exploration of Targeted Anti-Tumor Therapy|March 11, 2024
Management of stage III non-small-cell lung cancer: rays of hopeFloryane Kim, Maxime Borgeaud, Alfredo Addeo, et al.
Clinical Medicine Insights. Oncology|July 26, 2023
Pleural Mesothelioma in the Era of ImmunotherapyMathieu Chevallier, Floryane Kim, Alex Friedlaender, et al.
Revue Medicale Suisse|June 22, 2017
[Supportive care in oncology: a real change for patients?]Alex Friedlaender, Samuel Blaser, Christophe Luthy, et al.
Case Reports in Oncology|March 29, 2021
Vertebral Metastasis Treated by Vertebroplasty, a Cause of Respiratory Failure: Case Report and Literature ReviewMathieu Chevallier, Chloé Chevallier-Lugon, Alex Friedlaender, et al.
Pageof 11